Next Article in Journal

Efficacy of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Moderate-to-Severe COPD Exacerbations Among Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

Next Article in Special Issue

Thermogenic Targets for Obesity Management in the Era of Incretin-Based Therapies

Previous Article in Journal

Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus

Previous Article in Special Issue

Lycopene and Garcinia cambogia Induce White-to-Brown Adipose Differentiation: An Innovative Strategy to Curb Obesity

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessArticle

Article Versions Notes

Pharmaceuticals 2025, 18(9), 1336; https://doi.org/10.3390/ph18091336

Action	Date	Notes	Link
article pdf uploaded.	5 September 2025 15:43 CEST	Version of Record	https://www.mdpi.com/1424-8247/18/9/1336/pdf-vor
article supplementary file uploaded.	5 September 2025 15:43 CEST	-	https://www.mdpi.com/1424-8247/18/9/1336#supplementary
article xml file uploaded	8 September 2025 12:01 CEST	Original file	-
article xml uploaded.	8 September 2025 12:01 CEST	Update	https://www.mdpi.com/1424-8247/18/9/1336/xml
article pdf uploaded.	8 September 2025 12:01 CEST	Updated version of record	https://www.mdpi.com/1424-8247/18/9/1336/pdf
article html file updated	8 September 2025 12:04 CEST	Original file	https://www.mdpi.com/1424-8247/18/9/1336/html

Back to TopTop